Cargando…

Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease

BACKGROUND: Coats’ disease is a rare entity with retinal vascular telangiectasia that can progress to exudative retinal detachment, neovascular glaucoma, and a blind painful eye requiring enucleation. Despite recent therapeutic advances decreasing the need for enucleation, no consensus exists about...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowara, Mohamed, Fouad, Yousef A, Abdel Aziz, Ihab, Habib, Ahmed M, Al-feky, Mariam, Hassan, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853627/ https://www.ncbi.nlm.nih.gov/pubmed/33542620 http://dx.doi.org/10.2147/OPTH.S293030

Ejemplares similares

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
por: Menezes, Carlos, et al.
Publicado: (2015)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
por: Narayan, Daniel Sanju, et al.
Publicado: (2015)

Clinical and multimodal imaging characteristics of eyes with Vogt–Koyanagi–Harada disease: An Egyptian experience
por: Mekkawy, Mahmood O., et al.
Publicado: (2023)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama, Kei, et al.
Publicado: (2012)

Management of retinal artery macroaneurysm exudation in Wyburn-Mason syndrome with intravitreal ranibizumab
por: Naik, Anmol U, et al.
Publicado: (2019)

INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY
por: Lyu, Jiao, et al.
Publicado: (2021)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
por: Canan, Handan, et al.
Publicado: (2014)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki, Hiroyuki, et al.
Publicado: (2017)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas, Benjamin J, et al.
Publicado: (2016)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
por: Nakamura, Tomoko, et al.
Publicado: (2012)

Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
por: Marín-Lambíes, Cristina, et al.
Publicado: (2012)

Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes
por: Figurska, Małgorzata, et al.
Publicado: (2011)

AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study
por: Blanco-Garavito, Rocio, et al.
Publicado: (2018)

A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
por: Kitnarong, Naris, et al.
Publicado: (2015)

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab
por: Perdicchi, Andrea, et al.
Publicado: (2015)

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
por: Sonoda, Shozo, et al.
Publicado: (2013)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
por: Barthelmes, Daniel, et al.
Publicado: (2016)

The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats’ disease
por: Zhang, Longli, et al.
Publicado: (2018)

Perfluorocarbon liquid-assisted vitreo-dissection in eyes with firmly adherent posterior hyaloid
por: Aziz, Ihab Abdel, et al.
Publicado: (2022)

Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye
por: Peyman, Mohammadreza, et al.
Publicado: (2018)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

The Effect of Ranibizumab on Normal Neurosensory Retina in the Eyes of Patients with Exudative Age Related Macular Degeneration
por: Makri, Olga E., et al.
Publicado: (2017)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
por: Hamoudi, Hassan, et al.
Publicado: (2011)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Diabetic papillopathy treated with intravitreal ranibizumab
por: Yildirim, Mine, et al.
Publicado: (2017)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Optical Coherence Tomography Angiography Findings After Intravitreal Ranibizumab in Patients With Coats Disease
por: Cennamo, Gilda, et al.
Publicado: (2021)

Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection
por: Zhou, Minwen, et al.
Publicado: (2016)

Lucentis(®) using Visudyne(®) study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration
por: Chen, Eric, et al.
Publicado: (2010)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration
por: Pan, Hai-Tao, et al.
Publicado: (2020)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016)

Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
por: Noorlaila, Baharuddin, et al.
Publicado: (2016)

Current Smoking Is Associated with a Poor Visual Acuity Improvement after Intravitreal Ranibizumab Therapy in Patients with Exudative Age-Related Macular Degeneration
por: Lee, Sangmoon, et al.
Publicado: (2013)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
por: Chiu, Chiung-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_de8sooc87a97sjufdfn2vi6n1r